abiraterone acetate
Commercial- Indications
- Metastatic castration-resistant prostate cancer
Company intelligence / Profile preview
Tianjin Harmony Technology Development is a commercial-stage Chinese pharmaceutical manufacturer specializing in active pharmaceutical ingredients (APIs), intermediates, and chemical products. The company operates under GMP standards and holds ISO9001 certification. Its product portfolio includes APIs for oncology and hormone therapies as well as plant extracts with anti-tumor and immunosuppressive properties. Products are exported globally to North America, Europe, Asia-Pacific regions.[3][4][5][6]
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Harmony Technology Development.